drugset / Trial / NCT02786667
Non Motors Aspects in De Novo Parkinson's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
Clinical description and pathophysiological study of recently diagnosed untreated patients with Parkinson's Disease. Effect of a dopamine agonist (rotigotine) on apathy in de novo patients with Parkinson disease: A controlled, randomized, double blind study.
Timeline
- Start
- 2012-06
- Primary completion
- 2017-10-15
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 8 mg | — |